MaxCyte OverviewMaxCyte's common stock is $1.1M.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
MaxCyte (MXCT) currently reports a common stock of $1.1M as of March 2026. That compares with $1.1M in the prior-year period — up 0.8% year over year. Use the charts on this page to explore MaxCyte's common stock history and peer comparisons.
MaxCyte's common stock increased from $1.1M to $1.1M — a 0.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
MaxCyte reported $1.1M in common stock as of March 2026. That compares with $1.1M in the prior-year period — up 0.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MaxCyte, and consider following MXCT for alerts when major investors trade the stock.
MaxCyte is classified in the Materials sector. On common stock, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing MXCT with unrelated industries.
